Schedule 13D ownership disclosure

Wize Pharma, Inc.

Security class unavailable · CUSIP: 97751M207

Event date: 2020-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-009733
Form type
SC 13D/A
Filer
Danenberg Noam
CIK
CIK 1720898
Filed
Feb 16, 2021
Reporting period
Dec 29, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub